Global Cancer Testing/Screening Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 117 pages | ID: GE0B8A8EAADEN
GlobalInfoResearch

Abstracts

Screening means checking your body for cancer before you have symptoms.

Scope of the Report:

In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.

The global Cancer Testing/Screening market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Testing/Screening.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Cancer Testing/Screening market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Testing/Screening market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Dias Orin
• Epigenetics
• Techlab
• Positive Bioscience
• Genextropy
• M Genomics
• 20/20 GeneSystems
• AB SCIEX
• Abbott Laboratories

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Lung Cancer
• Blood Cancer
• Bone Cancer
• Gall Bladder Cancer
• Others

Market Segment by Applications, can be divided into

• Hospitals and Clinics
• Others

Contents

1 CANCER TESTING/SCREENING MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Testing/Screening
1.2 Classification of Cancer Testing/Screening by Types
  1.2.1 Global Cancer Testing/Screening Revenue Comparison by Types (2017-2023)
  1.2.2 Global Cancer Testing/Screening Revenue Market Share by Types in 2017
  1.2.3 Lung Cancer
  1.2.4 Blood Cancer
  1.2.5 Bone Cancer
  1.2.6 Gall Bladder Cancer
  1.2.7 Others
1.3 Global Cancer Testing/Screening Market by Application
  1.3.1 Global Cancer Testing/Screening Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals and Clinics
  1.3.3 Others
1.4 Global Cancer Testing/Screening Market by Regions
  1.4.1 Global Cancer Testing/Screening Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Cancer Testing/Screening Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Testing/Screening Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Testing/Screening Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Cancer Testing/Screening Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Testing/Screening Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Testing/Screening (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Dias Orin
  2.1.1 Business Overview
  2.1.2 Cancer Testing/Screening Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Dias Orin Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.2 Epigenetics
  2.2.1 Business Overview
  2.2.2 Cancer Testing/Screening Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Epigenetics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.3 Techlab
  2.3.1 Business Overview
  2.3.2 Cancer Testing/Screening Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Techlab Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.4 Positive Bioscience
  2.4.1 Business Overview
  2.4.2 Cancer Testing/Screening Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Positive Bioscience Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genextropy
  2.5.1 Business Overview
  2.5.2 Cancer Testing/Screening Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Genextropy Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.6 M Genomics
  2.6.1 Business Overview
  2.6.2 Cancer Testing/Screening Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 M Genomics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.7 20/20 GeneSystems
  2.7.1 Business Overview
  2.7.2 Cancer Testing/Screening Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 20/20 GeneSystems Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.8 AB SCIEX
  2.8.1 Business Overview
  2.8.2 Cancer Testing/Screening Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 AB SCIEX Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.9 Abbott Laboratories
  2.9.1 Business Overview
  2.9.2 Cancer Testing/Screening Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Abbott Laboratories Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CANCER TESTING/SCREENING MARKET COMPETITION, BY PLAYERS

3.1 Global Cancer Testing/Screening Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Cancer Testing/Screening Players Market Share
  3.2.2 Top 10 Cancer Testing/Screening Players Market Share
3.3 Market Competition Trend

4 GLOBAL CANCER TESTING/SCREENING MARKET SIZE BY REGIONS

4.1 Global Cancer Testing/Screening Revenue and Market Share by Regions
4.2 North America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CANCER TESTING/SCREENING REVENUE BY COUNTRIES

5.1 North America Cancer Testing/Screening Revenue by Countries (2013-2018)
5.2 USA Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

6 EUROPE CANCER TESTING/SCREENING REVENUE BY COUNTRIES

6.1 Europe Cancer Testing/Screening Revenue by Countries (2013-2018)
6.2 Germany Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.4 France Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CANCER TESTING/SCREENING REVENUE BY COUNTRIES

7.1 Asia-Pacific Cancer Testing/Screening Revenue by Countries (2013-2018)
7.2 China Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.5 India Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CANCER TESTING/SCREENING REVENUE BY COUNTRIES

8.1 South America Cancer Testing/Screening Revenue by Countries (2013-2018)
8.2 Brazil Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CANCER TESTING/SCREENING BY COUNTRIES

9.1 Middle East and Africa Cancer Testing/Screening Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)

10 GLOBAL CANCER TESTING/SCREENING MARKET SEGMENT BY TYPE

10.1 Global Cancer Testing/Screening Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Testing/Screening Market Forecast by Type (2018-2023)
10.3 Lung Cancer Revenue Growth Rate (2013-2023)
10.4 Blood Cancer Revenue Growth Rate (2013-2023)
10.5 Bone Cancer Revenue Growth Rate (2013-2023)
10.6 Gall Bladder Cancer Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)

11 GLOBAL CANCER TESTING/SCREENING MARKET SEGMENT BY APPLICATION

11.1 Global Cancer Testing/Screening Revenue Market Share by Application (2013-2018)
11.2 Cancer Testing/Screening Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)

12 GLOBAL CANCER TESTING/SCREENING MARKET SIZE FORECAST (2018-2023)

12.1 Global Cancer Testing/Screening Market Size Forecast (2018-2023)
12.2 Global Cancer Testing/Screening Market Forecast by Regions (2018-2023)
12.3 North America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.6 South America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Testing/Screening Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Testing/Screening Picture
Table Product Specifications of Cancer Testing/Screening
Table Global Cancer Testing/Screening and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Testing/Screening Revenue Market Share by Types in 2017
Figure Lung Cancer Picture
Figure Blood Cancer Picture
Figure Bone Cancer Picture
Figure Gall Bladder Cancer Picture
Figure Others Picture
Table Global Cancer Testing/Screening Revenue (Million USD) by Application (2013-2023)
Figure Cancer Testing/Screening Revenue Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Others Picture
Table Global Market Cancer Testing/Screening Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2013-2023)
Table Dias Orin Basic Information, Manufacturing Base and Competitors
Table Dias Orin Cancer Testing/Screening Type and Applications
Table Dias Orin Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Epigenetics Basic Information, Manufacturing Base and Competitors
Table Epigenetics Cancer Testing/Screening Type and Applications
Table Epigenetics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Techlab Basic Information, Manufacturing Base and Competitors
Table Techlab Cancer Testing/Screening Type and Applications
Table Techlab Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Positive Bioscience Basic Information, Manufacturing Base and Competitors
Table Positive Bioscience Cancer Testing/Screening Type and Applications
Table Positive Bioscience Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Genextropy Basic Information, Manufacturing Base and Competitors
Table Genextropy Cancer Testing/Screening Type and Applications
Table Genextropy Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table M Genomics Basic Information, Manufacturing Base and Competitors
Table M Genomics Cancer Testing/Screening Type and Applications
Table M Genomics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table 20/20 GeneSystems Basic Information, Manufacturing Base and Competitors
Table 20/20 GeneSystems Cancer Testing/Screening Type and Applications
Table 20/20 GeneSystems Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table AB SCIEX Basic Information, Manufacturing Base and Competitors
Table AB SCIEX Cancer Testing/Screening Type and Applications
Table AB SCIEX Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Cancer Testing/Screening Type and Applications
Table Abbott Laboratories Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Testing/Screening Revenue (Million USD) by Players (2013-2018)
Table Global Cancer Testing/Screening Revenue Share by Players (2013-2018)
Figure Global Cancer Testing/Screening Revenue Share by Players in 2016
Figure Global Cancer Testing/Screening Revenue Share by Players in 2017
Figure Global Top 5 Players Cancer Testing/Screening Revenue Market Share in 2017
Figure Global Top 10 Players Cancer Testing/Screening Revenue Market Share in 2017
Figure Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Cancer Testing/Screening Revenue (Million USD) by Regions (2013-2018)
Table Global Cancer Testing/Screening Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Testing/Screening Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Testing/Screening Revenue Market Share by Regions in 2017
Figure North America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Europe Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure South America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table North America Cancer Testing/Screening Revenue by Countries (2013-2018)
Table North America Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Testing/Screening Revenue Market Share by Countries in 2017
Figure USA Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Canada Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Mexico Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table Europe Cancer Testing/Screening Revenue (Million USD) by Countries (2013-2018)
Figure Europe Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure Europe Cancer Testing/Screening Revenue Market Share by Countries in 2017
Figure Germany Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure UK Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure France Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Russia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Italy Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Testing/Screening Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Testing/Screening Revenue Market Share by Countries in 2017
Figure China Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Japan Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Korea Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure India Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table South America Cancer Testing/Screening Revenue by Countries (2013-2018)
Table South America Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Testing/Screening Revenue Market Share by Countries in 2017
Figure Brazil Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Argentina Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Colombia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Testing/Screening Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure UAE Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Egypt Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure Nigeria Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Figure South Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
Table Global Cancer Testing/Screening Revenue (Million USD) by Type (2013-2018)
Table Global Cancer Testing/Screening Revenue Share by Type (2013-2018)
Figure Global Cancer Testing/Screening Revenue Share by Type (2013-2018)
Figure Global Cancer Testing/Screening Revenue Share by Type in 2017
Table Global Cancer Testing/Screening Revenue Forecast by Type (2018-2023)
Figure Global Cancer Testing/Screening Market Share Forecast by Type (2018-2023)
Figure Global Lung Cancer Revenue Growth Rate (2013-2018)
Figure Global Blood Cancer Revenue Growth Rate (2013-2018)
Figure Global Bone Cancer Revenue Growth Rate (2013-2018)
Figure Global Gall Bladder Cancer Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Cancer Testing/Screening Revenue by Application (2013-2018)
Table Global Cancer Testing/Screening Revenue Share by Application (2013-2018)
Figure Global Cancer Testing/Screening Revenue Share by Application (2013-2018)
Figure Global Cancer Testing/Screening Revenue Share by Application in 2017
Table Global Cancer Testing/Screening Revenue Forecast by Application (2018-2023)
Figure Global Cancer Testing/Screening Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Cancer Testing/Screening Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Cancer Testing/Screening Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
Figure Europe Cancer Testing/Screening Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Cancer Testing/Screening Revenue Market Forecast (2018-2023)
Figure South America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Cancer Testing/Screening Revenue Market Forecast (2018-2023)